Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3079)
All Articles published online
|
Oct 7, 2005 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Assy N, Bekirov I, Mejritsky Y, Solomon L, Szvalb S, Hussein O. Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases. World J Gastroenterol 2005; 11(37): 5834-5839 [PMID: 16270394 DOI: 10.3748/wjg.v11.i37.5834] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i37/5834.htm |
| Number | Citing Articles |
| 1 |
Pikkel Josef, Ibrahim Ali, Prober Ariel, Marmor Alon, Assy Nimer. Relationship between Retinal Vascular Caliber and Coronary Artery Disease in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD). International Journal of Environmental Research and Public Health 2013; 10(8): 3409 doi: 10.3390/ijerph10083409
|
| 2 |
|
| 3 |
Kayleigh L Wood, Michael H Miller, John F Dillon. Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease. BMJ Open Gastroenterology 2015; 2(1): e000019 doi: 10.1136/bmjgast-2014-000019
|
| 4 |
Mario D'Amico, Francesca Pasta, Linda Pasta. Thrombophilic genetic factors PAI-1 4G-4G and MTHFR 677TT as risk factors of alcohol, cryptogenic liver cirrhosis and portal vein thrombosis, in a Caucasian population. Gene 2015; 568(1): 85 doi: 10.1016/j.gene.2015.05.034
|
| 5 |
George V. Papatheodoridis, Nikolaos Chrysanthos, Evangelos Cholongitas, Efthymia Pavlou, George Apergis, Dina G. Tiniakos, Evangelia Andrioti, George Theodossiades, Athanasios J. Archimandritis. Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease. Journal of Hepatology 2009; 51(5): 931 doi: 10.1016/j.jhep.2009.06.023
|
| 6 |
Keren Borensztajn, Jan H. Von Der Thüsen, Maikel P. Peppelenbosch, C. Arnold Spek. The coagulation factor Xa/protease activated receptor‐2 axis in the progression of liver fibrosis: a multifaceted paradigm. Journal of Cellular and Molecular Medicine 2010; 14(1-2): 143 doi: 10.1111/j.1582-4934.2009.00980.x
|
| 7 |
Sebastian Hörber, Rainer Lehmann, Norbert Stefan, Jürgen Machann, Andreas L. Birkenfeld, Robert Wagner, Martin Heni, Hans-Ulrich Häring, Andreas Fritsche, Andreas Peter. Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance. Molecular Metabolism 2021; 53: 101262 doi: 10.1016/j.molmet.2021.101262
|
| 8 |
An Verrijken, Sven Francque, Ilse Mertens, Janne Prawitt, Sandrine Caron, Guy Hubens, Eric Van Marck, Bart Staels, Peter Michielsen, Luc Van Gaal. Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 2014; 59(1): 121 doi: 10.1002/hep.26510
|
| 9 |
M. A. Edens, F. Kuipers, R. P. Stolk. Non‐alcoholic fatty liver disease is associated with cardiovascular disease risk markers. Obesity Reviews 2009; 10(4): 412 doi: 10.1111/j.1467-789X.2009.00594.x
|
| 10 |
M. Knaapen, R.S. Kootte, E.G. Zoetendal, W.M. de Vos, G.M. Dallinga-Thie, M. Levi, E.S. Stroes, M. Nieuwdorp. Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota?. Clinical Microbiology and Infection 2013; 19(4): 331 doi: 10.1111/1469-0691.12170
|
| 11 |
Luan Rodrigues Abdallah, Ricardo Cardoso de Matos, Yves Pacheco Dias March e Souza, Débora Vieira-Soares, Gabriela Muller-Machado, Priscila Pollo-Flores. Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis. Current Atherosclerosis Reports 2020; 22(1) doi: 10.1007/s11883-020-0820-8
|
| 12 |
W Anthony Lizarraga, Samir Dalia, Steven E Reinert, Fred J Schiffman. Venous thrombosis in patients with chronic liver disease. Blood Coagulation & Fibrinolysis 2010; 21(5): 431 doi: 10.1097/MBC.0b013e328337b3ba
|
| 13 |
Jonathan G. Stine, Patrick G. Northup. Coagulopathy Before and After Liver Transplantation. Clinics in Liver Disease 2017; 21(2): 253 doi: 10.1016/j.cld.2016.12.003
|
| 14 |
Jinfang Liu, Tao Zuo, Liping Zhao, Yanchang Li, Lei Chang, Yali Zhang, Junzhu Wu, Ping Xu. Serum extracellular vesicle proteome differentiate early stage liver fibrosis. International Journal of Mass Spectrometry 2022; 482: 116936 doi: 10.1016/j.ijms.2022.116936
|
| 15 |
Hang Gong, Huang Zhong, Hui-Mei Xu, Xiong-Chang Liu, Liang-Ping Li, De-Kui Zhang. Insight into increased risk of portal vein thrombosis in nonalcoholic fatty liver disease. European Journal of Internal Medicine 2023; 114: 23 doi: 10.1016/j.ejim.2023.06.011
|
| 16 |
Xingshun Qi, Weirong Ren, Valerio De Stefano, Daiming Fan. Associations of Coagulation Factor V Leiden and Prothrombin G20210A Mutations With Budd–Chiari Syndrome and Portal Vein Thrombosis: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2014; 12(11): 1801 doi: 10.1016/j.cgh.2014.04.026
|
| 17 |
Doris Ogresta, Anna Mrzljak, Maja Cigrovski Berkovic, Ines Bilic-Curcic, Sanja Stojsavljevic-Shapeski, Lucija Virovic-Jukic. Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. Journal of Clinical and Translational Hepatology 2022; 10(2): 339 doi: 10.14218/JCTH.2021.00268
|
| 18 |
Jonathan G. Stine, Blake A. Niccum, Alex N. Zimmet, Nicolas Intagliata, Stephen H. Caldwell, Curtis K. Argo, Patrick G. Northup. Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis. Clinical and Translational Gastroenterology 2018; 9(3): e140 doi: 10.1038/s41424-018-0002-y
|
| 19 |
Tarek Saleh, Fadi Matta, Fadi Alali, Paul D. Stein. Venous Thromboembolism with Chronic Liver Disease. The American Journal of Medicine 2011; 124(1): 64 doi: 10.1016/j.amjmed.2010.08.014
|
| 20 |
Armando Tripodi, Anna L. Fracanzani, Massimo Primignani, Veena Chantarangkul, Marigrazia Clerici, Pier Mannuccio Mannucci, Flora Peyvandi, Cristina Bertelli, Luca Valenti, Silvia Fargion. Procoagulant imbalance in patients with non-alcoholic fatty liver disease. Journal of Hepatology 2014; 61(1): 148 doi: 10.1016/j.jhep.2014.03.013
|
| 21 |
Andrea Boccatonda, Lorenza Del Cane, Lara Marola, Damiano D’Ardes, Gianfranco Lessiani, Nicoletta di Gregorio, Claudio Ferri, Francesco Cipollone, Carla Serra, Francesca Santilli, Fabio Piscaglia. Platelet, Antiplatelet Therapy and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review. Life 2024; 14(4): 473 doi: 10.3390/life14040473
|
| 22 |
Nimer Assy, Agness Djibre, Raymond Farah, Maria Grosovski, Alon Marmor. Presence of Coronary Plaques in Patients with Nonalcoholic Fatty Liver Disease. Radiology 2010; 254(2): 393 doi: 10.1148/radiol.09090769
|
| 23 |
Luca Valenti, Elena Canavesi, Enrico Galmozzi, Paola Dongiovanni, Raffaela Rametta, Paolo Maggioni, Marco Maggioni, Anna Ludovica Fracanzani, Silvia Fargion. Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease. Journal of Hepatology 2010; 53(5): 927 doi: 10.1016/j.jhep.2010.05.023
|
| 24 |
Marco Matteo Ciccone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo, Gabriella Ricci, Santa Carbonara, Michele Gesualdo, Fiorella Devito, Annapaola Zito, Francesca Cortese, Pietro Scicchitano. Inflammatory bowel disease, liver diseases and endothelial function. Journal of Cardiovascular Medicine 2015; 16(1): 11 doi: 10.2459/JCM.0000000000000149
|
| 25 |
Maria Assunta Zocco, Enrico Di Stasio, Raimondo De Cristofaro, Marialuisa Novi, Maria Elena Ainora, Francesca Ponziani, Laura Riccardi, Stefano Lancellotti, Angelo Santoliquido, Roberto Flore, Maurizio Pompili, Gian Lodovico Rapaccini, Paolo Tondi, Giovanni Battista Gasbarrini, Raffaele Landolfi, Antonio Gasbarrini. Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development. Journal of Hepatology 2009; 51(4): 682 doi: 10.1016/j.jhep.2009.03.013
|
| 26 |
Jingwen Du, Jinming Zhang, Xiaojing Chen, Shuoqi Zhang, Cong Zhang, Huan Liu, Yueyue Li, Mengdi Li, Xiaoming Wu, Mengqi Xiang, Chengyue Wang, Langjiao Liu, Chunli Wang, Shaohong Fang, Jialan Shi. Neutrophil extracellular traps induced by pro-inflammatory cytokines enhance procoagulant activity in NASH patients. Clinics and Research in Hepatology and Gastroenterology 2022; 46(1): 101697 doi: 10.1016/j.clinre.2021.101697
|
| 27 |
Laura Turco, Filippo Schepis, Erica Villa. The Role of Anticoagulation in Treating Portal Hypertension. Current Hepatology Reports 2018; 17(3): 200 doi: 10.1007/s11901-018-0406-x
|
| 28 |
Chandini Rangaswamy, Reiner K. Mailer, Hanna Englert, Sandra Konrath, Thomas Renné. The contact system in liver injury. Seminars in Immunopathology 2021; 43(4): 507 doi: 10.1007/s00281-021-00876-7
|
| 29 |
Xingshun Qi, Guohong Han, Daiming Fan. Management of portal vein thrombosis in liver cirrhosis. Nature Reviews Gastroenterology & Hepatology 2014; 11(7): 435 doi: 10.1038/nrgastro.2014.36
|
| 30 |
Dmitri Bezinover, Seyedehsan Navabi, Ming Wang, Zheng Li, Meryl William, Jonathan G. Stine. Hyponatremia Is Protective Against the Development of Portal Vein Thrombosis in Patients Undergoing Liver Transplant. Transplantation Proceedings 2019; 51(6): 1880 doi: 10.1016/j.transproceed.2019.05.014
|
| 31 |
Armando Tripodi, Rosa Lombardi, Massimo Primignani, Vincenzo La Mura, Flora Peyvandi, Anna L. Fracanzani. Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences. Biomedicines 2022; 10(2): 249 doi: 10.3390/biomedicines10020249
|
| 32 |
Niccolò Bitto, Eleonora Liguori, Vincenzo Mura. Coagulation, Microenvironment and Liver Fibrosis. Cells 2018; 7(8): 85 doi: 10.3390/cells7080085
|
| 33 |
Anna Kotronen, Lotta Joutsi-Korhonen, Ksenia Sevastianova, Robert Bergholm, Antti Hakkarainen, Kirsi H. Pietiläinen, Nina Lundbom, Aila Rissanen, Riitta Lassila, Hannele Yki-Järvinen. Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease. Liver International 2011; 31(2): 176 doi: 10.1111/j.1478-3231.2010.02375.x
|
| 34 |
Jason Yerke, Seth R. Bauer, Stephanie Bass, Heather Torbic, Michael Militello, Erin Roach, Ibrahim Hanouneh, Sarah Welch. Effectiveness of venous thromboembolism prophylaxis in patients with liver disease. World Journal of Hepatology 2019; 11(4): 379-390 doi: 10.4254/wjh.v11.i4.379
|
| 35 |
Patrick G. Northup. Hypercoagulation in Liver Disease. Clinics in Liver Disease 2009; 13(1): 109 doi: 10.1016/j.cld.2008.09.003
|
| 36 |
Tasur Kumar Seen, Muntazir Sayed, Muhammad Bilal, Jonathan Vincent Reyes, Priyanka Bhandari, Vennis Lourdusamy, Ahmed Al-khazraji, Umer Syed, Yasar Sattar, Raghav Bansal. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. World Journal of Gastroenterology 2021; 27(23): 3238-3248 doi: 10.3748/wjg.v27.i23.3238
|
| 37 |
Sonal Sharma, Jonathan G. Stine, Thomas Verbeek, Dmitri Bezinover. Management of Patients With Non-alcoholic Steatohepatitis Undergoing Liver Transplantation: Considerations for the Anesthesiologist. Journal of Cardiothoracic and Vascular Anesthesia 2022; 36(8): 2616 doi: 10.1053/j.jvca.2021.07.020
|
| 38 |
Dominique Charles Valla. Thrombosis and anticoagulation in liver disease. Hepatology 2008; 47(4): 1384 doi: 10.1002/hep.22192
|
| 39 |
W. Nseir, A. Shalata, A. Marmor, N. Assy. Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease. Digestive Diseases and Sciences 2011; 56(12): 3439 doi: 10.1007/s10620-011-1767-y
|
| 40 |
Wilma Potze, Mohammad S. Siddiqui, Sherry L. Boyett, Jelle Adelmeijer, Kalyani Daita, Arun J. Sanyal, Ton Lisman. Preserved hemostatic status in patients with non-alcoholic fatty liver disease. Journal of Hepatology 2016; 65(5): 980 doi: 10.1016/j.jhep.2016.06.001
|
| 41 |
Marwan Ghabril, Saurabh Agarwal, Marco Lacerda, Naga Chalasani, Paul Kwo, A. Joseph Tector. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation. Transplantation 2016; 100(1): 126 doi: 10.1097/TP.0000000000000785
|
| 42 |
Paola Loria, Amedeo Lonardo, Giovanni Targher. Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis. Clinical Science 2008; 115(1): 1 doi: 10.1042/CS20070311
|
| 43 |
Johanna Ohlendorf, Hella Kiene, Jessica Wiegandt, André Karch, Veronika K. Jaeger, Tobias Laue, Norman Junge, Frauke Mutschler, Imeke Goldschmidt, Eva-Doreen Pfister, Christoph Leiskau, Claus Petersen, Omid Madadi-Sanjani, Joachim Friedrich Kuebler, Juliane Katharina Götz, Ulrich Baumann. The Impact of Thrombophilic Factors on Disease Progression in Children with Biliary Atresia—A Single-Centre Cohort Study. Journal of Clinical Medicine 2023; 12(6): 2108 doi: 10.3390/jcm12062108
|
| 44 |
Alison J. Dawson, Thozhukat Sathyapalan, Jacqueline A. J. Smithson, Rebecca V. Vince, Anne‐Marie Coady, Ramzi Ajjan, Eric S. Kilpatrick, Stephen L. Atkin. A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease. Clinical Endocrinology 2014; 80(6): 843 doi: 10.1111/cen.12258
|
| 45 |
Jesús Monterrubio Villar, Alberto Córdoba López. Trombosis mesentérica y déficit de proteínas C y S en un paciente con hepatitis C crónica en tratamiento con interferón y ribavirina. Gastroenterología y Hepatología 2007; 30(5): 271 doi: 10.1157/13101976
|
| 46 |
P.G. NORTHUP, V. SUNDARAM, M.B. FALLON, K.R. REDDY, R.A. BALOGUN, A.J. SANYAL, Q.M. ANSTEE, M.R. HOFFMAN, Y. IKURA, S.H. CALDWELL. Hypercoagulation and thrombophilia in liver disease. Journal of Thrombosis and Haemostasis 2008; 6(1): 2 doi: 10.1111/j.1538-7836.2007.02772.x
|